Ocumension Therapeutics
HKEX:1477

Watchlist Manager
Ocumension Therapeutics Logo
Ocumension Therapeutics
HKEX:1477
Watchlist
Price: 4.41 HKD 0.46% Market Closed
Market Cap: 3.6B HKD
Have any thoughts about
Ocumension Therapeutics?
Write Note

Ocumension Therapeutics
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ocumension Therapeutics
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Ocumension Therapeutics
HKEX:1477
Total Current Liabilities
ÂĄ315.3m
CAGR 3-Years
51%
CAGR 5-Years
139%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Current Liabilities
ÂĄ6.9B
CAGR 3-Years
37%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Current Liabilities
ÂĄ2.5B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
26%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Current Liabilities
ÂĄ4.8B
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
20%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Current Liabilities
ÂĄ13.8B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
14%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Current Liabilities
ÂĄ1.1B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ocumension Therapeutics
Glance View

Market Cap
3.6B HKD
Industry
Pharmaceuticals

Ocumension Therapeutics engages in the identification, development, and commercialization of ophthalmic therapies. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-07-10. Its main products include OT-401 (YUTIQ), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-301 (NCX 470), OT-101 and OT-202, among others. The firm conducts its businesses in the domestic market.

Intrinsic Value
5.8 HKD
Undervaluation 24%
Intrinsic Value
Price

See Also

What is Ocumension Therapeutics's Total Current Liabilities?
Total Current Liabilities
315.3m CNY

Based on the financial report for Dec 31, 2023, Ocumension Therapeutics's Total Current Liabilities amounts to 315.3m CNY.

What is Ocumension Therapeutics's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
139%

Over the last year, the Total Current Liabilities growth was 27%. The average annual Total Current Liabilities growth rates for Ocumension Therapeutics have been 51% over the past three years , 139% over the past five years .

Back to Top